Class Action Complaint in Winston Peete v, BioLineRx Ltd., described as “a pre-commercial stage biopharmaceutical company focused on oncology, headquartered [in] Israel”, and Philip A. Serlin at the U.S. District Court for the District of New Jersey.
- Home
- Documents
- Type
- Court Filings
- Civil
- Winston Peete v. BioLineRx Ltd. et al: Class Action Complaint (‘Securities Fraud’)
Civil Class Action Complaint Courts Documents Fraud Investment Israel Listed Securities United States District Court for the District of New Jersey USAJanuary 5, 2023
Winston Peete v. BioLineRx Ltd. et al: Class Action Complaint (‘Securities Fraud’)
21
January 05, 2023
BioLineRx Ltd., Philip A. Serlin
Winston Peete
Topics
Fraud Investment Israel Listed Securities USAKeywords
Philip Serlin Winston Peete